Executive Summary
AI
- Michael Schmidt walks through an open-access Cell paper published November 26, 2025 by a team of 11 from Stanford University, the Chan Zuckerberg Biohub, West Link University in Hangzhou and Tsinghua University in Beijing, titled "Nutrient Competition Predicts Gut Microbiome Restructuring under drug perturbations".3:23
- Screening over 700 clinically relevant drugs, the authors found 141 common medications significantly alter the microbiome, including the blood pressure drug Losartan that Schmidt himself takes.6:22
- The driver is not toxicity but fitness: a tug of war in which the bacteria best at grabbing the remaining nutrients win the day, some species go extinct and never come back, and 51 of the 69 antibacterial drugs inhibited growth while anti-neoplastic agents actually enriched growth.7:46
- Mark O. Martin then presents a Nature Microbiology paper from Cambridge, the United Arab Emirates University and Royal Papworth Hospital, by Santiago Caño Muñez, Floto and many co-authors, combining microbial genetics, single-cell imaging, labelled substrates and optogenetics.29:37
- They show porin permeability is regulated by periplasmic hydrogen and potassium ions: a light-activated proton pump switched on with green light at 541 nanometers acidifies the periplasm and the porins close in real time, so the metabolic state of the bacterium decides how much hydrophilic antibiotic gets in.33:48
Key Quote
“Simply, it's a tug of war.”
— Michael Schmidt6:59
Key Quote
“So Michael, what did they do?”
— Vincent Racaniello11:33
Key Quote
“So I think the way to look at this paper is not what it tells us, but how it's analyzing the problem.”
— Petra Levin21:55